A Portfolio of Treatments for Migraine Patients
Thursday, June 9, 2022 6:45 PM to 7:45 PM · 1 hr. (America/Denver)
Adams B/C
Industry Event
Information
Industry-Sponsored Event
Sponsored by AbbVie, Inc.
Not Eligible for CME Credits
Brad C. Klein, MD, MBA
Abington Neurological Associates, LTD
Bolstered by the Allergan neuroscience legacy, AbbVie is a committed leader in migraine with an almost 25-year history in migraine research. Our current migraine treatments demonstrate our dedication to addressing the unmet needs of migraine and chronic migraine patients – and we continue to strive for science that makes a difference.
